A newly designed microarray core, including a newly hired manager, and faculty leader, has been established since November, 2004, with the purpose of offering full service, affordable, microarray services to Cancer Center members. The Core operates in conjunction with support from the Department of Medicine and has close links to the School of Medicine Affymetrix core and is seamlessly linked to the new Bioinformatics Core in the Cancer Center. Using the long-oligo Agilent platform, the Center Core offers full 40K human, and mouse, 23 K rat, and 10K yeast gene expression coverage. The facility also has the capacity to utilize custom gene expression arrays from Agilent and has facilities for printing custom human, mouse, and canine cDNA arrays as well. Most recently, the Core offers an Agilent 44K gene transcript oligo based CGH coverage for comprehensive structural analysis of all human chromosomes. The full service offered to investigators includes optional RNA and DNA extraction, QC of RNA and DNA samples, hybridization, scanning and provision of an annotated gene list, or detailed chromosome maps for CGH data, with Agilent software analysis of statistical significance of gene expression changes, etc. In conjunction with the Bioinformatics Core, users are offered instruction for full data analyses, with consultation and collaborative links to the Bioinformatics Core for the most sophisticated needs. Powerful Bioconductor software has been adapted, by the Informatics Core, for encompassing Agilent data. Regular microarray seminars, arranged by the Bioinformatics Core, and presentations by Agilent and other array offering companies, arranged by the Microarray Core, are made available to all users and Center members and also to the School of Medicine community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-47
Application #
7821295
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
47
Fiscal Year
2009
Total Cost
$197,779
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Yuan, Ming; Da Silva, Ana Cristina A L; Arnold, Antje et al. (2018) MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Sci Rep 8:12506
Jacobs, Michael A; Macura, Katarzyna J; Zaheer, Atif et al. (2018) Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Acad Radiol 25:1405-1414
Annesley, Colleen E; Rabik, Cara; Duffield, Amy S et al. (2018) Knock-in of the Wt1 R394W mutation causes MDS and cooperates with Flt3/ITD to drive aggressive myeloid neoplasms in mice. Oncotarget 9:35313-35326
Liu, Tao; Ivaturi, Vijay; Sabato, Philip et al. (2018) Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship. Clin Transl Sci 11:435-443
Goodman, Melody; Lyons, Sarah; Dean, Lorraine T et al. (2018) How Segregation Makes Us Fat: Food Behaviors and Food Environment as Mediators of the Relationship Between Residential Segregation and Individual Body Mass Index. Front Public Health 6:92
Ramos, Juan C; Sparano, Joseph A; Rudek, Michelle A et al. (2018) Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk 18:180-190.e2
Wei, Ting; Najmi, Saman M; Liu, Hester et al. (2018) Small-Molecule Targeting of RNA Polymerase I Activates a Conserved Transcription Elongation Checkpoint. Cell Rep 23:404-414
Kasamon, Yvette L; Fuchs, Ephraim J; Zahurak, Marianna et al. (2018) Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation. Biol Blood Marrow Transplant 24:1022-1028
Wang, Yuxuan; Li, Lu; Douville, Christopher et al. (2018) Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med 10:
Walter, Vonn; Du, Ying; Danilova, Ludmila et al. (2018) MVisAGe Identifies Concordant and Discordant Genomic Alterations of Driver Genes in Squamous Tumors. Cancer Res 78:3375-3385

Showing the most recent 10 out of 2393 publications